Personalized medicine and CRISPR-babies, gene modification of animals and plants, bioinformatics and big data, biohacking and ethical limits – what are the implications of gene editing? Since the discovery of CRISPR-Cas9 in 2012 – a biochemical tool to edit and change DNA with great precision – there has been a public conversation about the previously unimaginably acurate modification of genes, in humans, animals and plants.
The lecture series will present current research to a broad audience. Scholars from a variety of disciplines (e.g. veterinarian medicine, plant science, biomedicine, philosophy and law) have been invited to expound on the possibilities and challenges presented by gene technology.